bf/NASDAQ:AERI_icon.jpeg

COM:AERIEPHARMA

Aerie Pharmaceuticals, Inc.

  • Stock

Last Close

15.25

18/11 21:00

Volume Today

1.22M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-31.15M
-
-48.13M
54.53%
-74.36M
54.49%
-99.06M
33.21%
-145.10M
46.48%
-232.57M
60.28%
-199.58M
14.18%
-183.10M
8.26%
-74.81M
59.14%
depreciation and amortization
64K
-
73K
14.06%
252K
245.21%
970K
284.92%
1.41M
45.36%
2.44M
73.19%
18.11M
641.77%
34.16M
88.57%
37.50M
9.78%
deferred income tax
stock based compensation
2.86M
-
9.18M
221.13%
12.95M
41.04%
16.79M
29.73%
26.08M
55.28%
38.73M
48.51%
45.09M
16.44%
40.09M
11.08%
29.52M
26.36%
change in working capital
2.12M
-
4.66M
120.26%
4.54M
2.53%
627K
86.20%
-1.31M
309.57%
13.39M
1,118.87%
-23.96M
278.94%
44.89M
287.39%
-92.56M
306.20%
accounts receivables
-2.71M
-
-35.64M
1,212.67%
-17.67M
50.43%
-12.81M
27.52%
inventory
-9.69M
-
-10.26M
5.86%
-5.17M
49.63%
-12.10M
134.24%
accounts payables
2.04M
-
4.83M
136.14%
5.38M
11.51%
2.48M
53.96%
925K
62.69%
26.58M
2,773.84%
-270.75M
1,118.52%
16.87M
106.23%
21.58M
27.95%
other working capital
72K
-
-166K
330.56%
-840K
406.02%
-1.85M
120.48%
-2.24M
20.90%
-791K
64.67%
292.69M
37,103.03%
50.86M
82.62%
-89.23M
275.46%
other non cash items
9.66M
-
493K
94.90%
875K
77.48%
828K
5.37%
25.72M
3,006.04%
25.43M
1.10%
9.90M
61.08%
-732K
107.39%
1.19M
263.11%
net cash provided by operating activities
-16.45M
-
-33.73M
105.05%
-55.75M
65.29%
-79.84M
43.22%
-93.21M
16.75%
-152.58M
63.69%
-150.43M
1.41%
-64.69M
57.00%
-99.15M
53.28%
investments in property plant and equipment
-63K
-
-181K
187.30%
-3.28M
1,712.15%
-5.08M
54.79%
-15.97M
214.56%
-31.31M
96.07%
-9.96M
68.20%
-3.10M
68.87%
-3.29M
6.16%
acquisitions net
597K
-
3.85M
544.89%
5.60M
45.51%
-10.50M
287.43%
purchases of investments
-95.38M
-
-46.87M
50.86%
-35.17M
24.97%
-104.49M
197.11%
-56.20M
46.22%
-165.45M
194.43%
-116.59M
29.53%
-132.36M
13.53%
sales maturities of investments
22.24M
-
59.53M
167.70%
58.35M
2.00%
88.15M
51.09%
108.30M
22.85%
192.87M
-
117.45M
39.10%
other investing activites
-597K
-
-3.85M
544.89%
-5.60M
45.51%
-7.83M
-
net cash used for investing activites
-63K
-
-73.32M
116,277.78%
9.38M
112.80%
18.10M
92.92%
-42.81M
336.50%
20.79M
148.56%
-183.25M
981.46%
73.18M
139.93%
-18.20M
124.87%
debt repayment
-8.27M
-
common stock issued
71.87M
-
50.45M
-
168.48M
233.95%
134.22M
20.34%
135.97M
1.31%
684K
99.50%
-859K
225.58%
2.97M
445.98%
common stock repurchased
dividends paid
other financing activites
11.37M
-
122.98M
982.10%
1.39M
98.87%
146K
89.47%
1.43M
878.77%
1.06M
25.54%
274.12M
25,662.69%
8.27M
96.98%
net cash used provided by financing activities
83.23M
-
122.98M
47.75%
51.84M
57.85%
168.63M
225.29%
135.64M
19.56%
137.04M
1.03%
274.80M
100.53%
-859K
100.31%
2.97M
445.98%
effect of forex changes on cash
net change in cash
66.72M
-
15.94M
76.12%
5.47M
65.65%
106.89M
1,852.59%
-376K
100.35%
5.25M
1,496.01%
-58.88M
1,221.70%
7.63M
112.96%
-114.38M
1,599.12%
cash at beginning of period
2.92M
-
69.65M
2,281.16%
85.59M
22.88%
91.06M
6.40%
197.94M
117.38%
197.57M
0.19%
202.82M
2.66%
143.94M
29.03%
151.57M
5.30%
cash at end of period
69.65M
-
85.59M
22.88%
91.06M
6.40%
197.94M
117.38%
197.57M
0.19%
202.82M
2.66%
143.94M
29.03%
151.57M
5.30%
37.19M
75.47%
operating cash flow
-16.45M
-
-33.73M
105.05%
-55.75M
65.29%
-79.84M
43.22%
-93.21M
16.75%
-152.58M
63.69%
-150.43M
1.41%
-64.69M
57.00%
-99.15M
53.28%
capital expenditure
-63K
-
-181K
187.30%
-3.28M
1,712.15%
-5.08M
54.79%
-15.97M
214.56%
-31.31M
96.07%
-9.96M
68.20%
-3.10M
68.87%
-3.29M
6.16%
free cash flow
-16.51M
-
-33.91M
105.36%
-59.03M
74.08%
-84.92M
43.86%
-109.18M
28.58%
-183.89M
68.42%
-160.39M
12.78%
-67.79M
57.73%
-102.44M
51.12%

All numbers in (except ratios and percentages)